Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics

被引:46
作者
Booman, M.
Douwes, J.
Glas, A. M.
de Jong, D.
Schuuring, E.
Kluin, P. M.
机构
[1] Univ Groningen, Med Ctr, Dept Pathol & Lab Med, Groningen, Netherlands
[2] Agendia, Dept Bioinformat, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
关键词
diffuse large B-cell lymphoma; immune-privileged site; activated B-cell-like subtype; gene expression analysis; somatic hypermutation; immunohistochemistry;
D O I
10.1002/path.2033
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Diffuse large B-cell lymphomas (DLBCLs) constitute a heterogeneous group of lymphomas in which germinal centre B-cell-like and activated B-cell-like subtypes can be discerned based on pathology, clinical presentation, and gene expression patterns. Testicular DLBCLs form an immune-privileged site-related subgroup of DLBCLs with an unfavourable prognosis. In the present study, cDNA microarray analysis, immunohistochemistry for CD10, Bc16 and NUM1, and somatic hypermutation analysis of the immunoglobulin heavy chain gene rearrangements were used to determine the subtype of primary testicular DLBCL. Immunohistochemistry revealed 14/22 testicular DLBCLs with an activated B-cell-like immunophenotype and 8/22 with an ambiguous immunophenotype co-expressing CD10 and high levels of MUM1. cDNA microarray analysis of these 22 and four additional cases showed a uniform activated B-cell-like gene expression pattern for both immunophenotypes. Somatic hypermutation analysis of immunoglobulin heavy chain genes showed a very high mutation load in seven cases tested, but intraclonal heterogeneity was found at low level in only one of these cases. It is concluded that primary testicular DLBCLs have uniform activated B-cell-like subtype characteristics despite a number of cases showing an ambiguous immunophenotype. Copyright (c) 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 58 条
[1]
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]
Banham AH, 2005, CLIN CANCER RES, V11, P1065
[3]
Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome [J].
Barrans, SL ;
Fenton, JAL ;
Banham, A ;
Owen, RG ;
Jack, AS .
BLOOD, 2004, 104 (09) :2933-2935
[4]
Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma [J].
Barrans, SL ;
Carter, I ;
Owen, RG ;
Davies, FE ;
Patmore, RD ;
Haynes, AP ;
Morgan, GJ ;
Jack, AS .
BLOOD, 2002, 99 (04) :1136-1143
[5]
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis [J].
Berglund, M ;
Thunberg, U ;
Amini, RM ;
Book, M ;
Roos, G ;
Erlanson, M ;
Linderoth, J ;
Dictor, M ;
Jerkeman, M ;
Cavallin-Ståhl, E ;
Sundström, C ;
Rehn-Eriksson, S ;
Backlin, C ;
Hagberg, H ;
Rosenquist, R ;
Enblad, G .
MODERN PATHOLOGY, 2005, 18 (08) :1113-1120
[6]
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma [J].
Booman, M ;
Douwes, J ;
Glas, AM ;
Riemersma, SA ;
Jordanova, ES ;
Kok, K ;
Rosenwald, A ;
de Jong, D ;
Schuuring, E ;
Kluin, PM .
CLINICAL CANCER RESEARCH, 2006, 12 (09) :2698-2705
[7]
Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q [J].
Boonstra, R ;
Koning, A ;
Mastik, M ;
van den Berg, A ;
Poppema, S .
VIRCHOWS ARCHIV, 2003, 443 (02) :164-169
[8]
A uniform activated B-cell-like in-immunophenotype might explain the poor prognosis of primary central nervous system lymphomas:: analysis of 83 cases [J].
Camilleri-Broët, S ;
Crinière, E ;
Broët, P ;
Delwail, V ;
Mokhtari, K ;
Moreau, A ;
Kujas, M ;
Raphaël, M ;
Iraqi, W ;
Sautès-Fridman, C ;
Colombat, P ;
Hoang-Xuan, K ;
Martin, A .
BLOOD, 2006, 107 (01) :190-196
[9]
Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma [J].
Chang, CC ;
McClintock, S ;
Cleveland, RP ;
Trzpuc, T ;
Vesole, DH ;
Logan, B ;
Kajdacsy-Balla, A ;
Perkins, SL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (04) :464-470
[10]
Multiple sequence alignment with the Clustal series of programs [J].
Chenna, R ;
Sugawara, H ;
Koike, T ;
Lopez, R ;
Gibson, TJ ;
Higgins, DG ;
Thompson, JD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3497-3500